 |
|
New Knowledge, Old Patients
David A. Brechtelsbauer, MD
Arch Fam Med. 1995;4(12):1014-1016.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet. 1989;1:175-179.
PUBMED
2. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990;323:1505-1511.
ABSTRACT
3. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation. 1991;84:527-539.
FREE FULL TEXT
4. Connolly SJ, Laupacis A, Gent M, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991;18:349-355.
ABSTRACT
5. Ezekowitz EM, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1992;327:1406-1412.
ABSTRACT
6. Laupacis A, Albers G, Dunn M, et al. Antithrombotic therapy in atrial fibrillation. Chest. 1992;102(suppl_4):426S-433S.
PUBMED
7. Starkey I, Warlow C. Controversies in neurology: the secondary prevention of stroke in patients with atrial fibrillation. Arch Neurol. 1986;43:66-68.
FREE FULL TEXT
8. Sherman DG, Hart RG, Easton JD. The secondary prevention of stroke in patients with atrial fibrillation. Arch Neurol. 1986;43:68-70.
FREE FULL TEXT
9. Hachinski V. Atrial fibrillation and recurrent stroke. Arch Neurol. 1986;43:70.
FREE FULL TEXT
10. Cook DJ, Guyatt DG, et al. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1992;102(suppl 4):305S-311S.
PUBMED
11. Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994;74:236-241.
PUBMED
12. The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med. 1995;333:5-10.
FREE FULL TEXT
13. Finn SD. Aiming for safe anticoagulation. N Engl J Med. 1995;333:54-55.
FREE FULL TEXT
14. Lackner TE, Battis GN. Use of warfarin for nonvalvular atrial fibrillation in nursing home patients. Arch Fam Med. 1995;4:1017-1026.
FREE FULL TEXT
15. Tinetti ME. Factors associated with serious injury during falls by ambulatory nursing home residents. J Am Geriatr Soc. 1987;35:644-648.
PUBMED
16. Volicer L, Rheaume Y, Brown J, et al. Hospice approach to the treatment of patients with advance dementia of the Alzheimer type. JAMA. 1986;256:2210-2213.
FREE FULL TEXT
17. Wetle T. Age as a risk factor for inadequate treatment. JAMA. 1987;258:516.
PUBMED
18. Gurwitz JH, Avorn J, Ross-Degnan D, et al. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med. 1992;116:901-904.
FREE FULL TEXT
19. Avorn J. Benefit and cost analysis in geriatric care: turning age discrimination into health policy. N Engl J Med. 1984;310:1294-1301.
PUBMED
20. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med. 1992;117:684-689.
FREE FULL TEXT
|
